B
Bafna Pharmaceuticals
BAFNAPH Share Price
Healthcare106.15
as on 27 Feb 2026 at 15:29
Market Cap
₹251 Cr
PE Ratio
26.00
ROCE
-3.30%
BAFNAPH Fundamentals
Company Valuation
Market Cap (₹ Cr.)
251
PE Ratio
26.00
PB Ratio
2.76
Dividend Yield
-
ROE
-3.68%
ROCE
-3.30%
Book Value (₹)
38.56
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 88.30% | 75.00% | 75.00% | 75.00% | 75.00% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 8.53% | 9.34% | 9.34% | 9.34% |
| Public Investors | 7.66% | 11.06% | 11.62% | 12.03% | 12.13% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
BAFNAPH Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
532989
NSE Scrip Name
BAFNAPH
ISIN
INE878I01022



